z-logo
Premium
ADVATE prophylaxis: post hoc analysis of joint bleeding episodes
Author(s) -
Valentino L. A.,
Reyes C. M.,
Ewenstein B.,
GuzmánBecerra N.,
Wong W. Y.,
SchoenigDiesing C.,
Romanov V.
Publication year - 2014
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.12382
Subject(s) - medicine , interquartile range , post hoc analysis , on demand , gastroenterology , surgery , computer science , multimedia
Summary Introduction The ADVATE ( rAHF ‐PFM) Prophylaxis Study compared the efficacy of (i) standard factor (F) VIIII prophylaxis (SP) (20–40 IU kg −1 every other day) vs. pharmacokinetic‐tailored prophylaxis (PKP) (20–80 IU kg −1 every third day) and (ii) both prophylactic regimens with on‐demand therapy (OD) in 66 previously on‐demand‐treated patients (median age: 26 years; range: 7–59) with FVIII ≤2% and ≥8 joint haemorrhages in the year before enrolment. Aim The aim of this study was to evaluate joint bleeding episodes during the on‐demand and prophylactic study periods. Methods A post hoc analysis of joint bleeding episodes in the per protocol analysis set ( n  = 53) was conducted. Results The annualized joint bleeding rate ( AJBR ) was significantly lower for subjects treated with 12 months of SP ( n  = 30) or PKP ( n  = 23) as compared with 6 months of OD ( n  = 53): 55 {median AJBR 0.48 [interquartile range ( IQR ) 1.96]}, 72 [1.00 (4.07)] and 1164 [38.65 (24.81)] respectively ( P  < 0.0001). Median AJBR was comparable during both prophylaxis arms (0.5 and 1.0 respectively). In contrast, median AJBR during on‐demand therapy was 38.7 ( P  < 0.0001). Conclusion Both SP and PKP significantly increased the median number of days between joint bleeding episodes compared with OD : 268.9, 182.9 and 7.4 respectively ( P  < 0.0001). Study subjects experienced these joint‐protective benefits of prophylaxis regardless of the number of baseline target joints.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here